Tags

Type your tag names separated by a space and hit enter

Juvenile nasopharyngeal angiofibroma: management and therapy.
Laryngoscope 2001; 111(4 Pt 1):681-7L

Abstract

OBJECTIVE

To conduct a review of contemporary approaches on the diagnostic-preoperative, operative, and postoperative methods in the management of juvenile nasopharyngeal angiofibroma (JNA).

STUDY DESIGN

Retrospective study of 14 cases of JNA resection at the Department of Otorhinolaryngology, University of Innsbruck (Innsbruck, Austria) between 1987 and 1998.

METHODS

Data was obtained for each patient regarding age, presenting symptoms, duration of symptoms, biopsy findings, tumor location, administration of preoperative angiography and embolization, and surgical approach. The follow-up period ranged from 1 to 13 years.

RESULTS

Based on the histological evaluation by the preoperative biopsy and the tumor location, several surgical approaches were applied. A transnasal endoscopic procedure was employed in seven cases. The preoperative embolization and the intranasal approach with the potassium titanyl phosphate laser minimized blood loss. The recurrence rate was at a low of 15%.

CONCLUSION

The surgical approach should be determined by tumor location, tumor size, and effectiveness of tumor embolization. For patients with JNA with tumor extension involving the nasopharynx, the nasal cavity, the paranasal sinuses, and the pterygopalatine fossa, the transnasal endoscopic technique offers a minimally invasive resection of the entire tumor mass with minimal morphological disturbance.

Authors+Show Affiliations

Department of Otorhinolaryngology, University of Innsbruck, Innsbruck, Austria.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

11359140

Citation

Scholtz, A W., et al. "Juvenile Nasopharyngeal Angiofibroma: Management and Therapy." The Laryngoscope, vol. 111, no. 4 Pt 1, 2001, pp. 681-7.
Scholtz AW, Appenroth E, Kammen-Jolly K, et al. Juvenile nasopharyngeal angiofibroma: management and therapy. Laryngoscope. 2001;111(4 Pt 1):681-7.
Scholtz, A. W., Appenroth, E., Kammen-Jolly, K., Scholtz, L. U., & Thumfart, W. F. (2001). Juvenile nasopharyngeal angiofibroma: management and therapy. The Laryngoscope, 111(4 Pt 1), pp. 681-7.
Scholtz AW, et al. Juvenile Nasopharyngeal Angiofibroma: Management and Therapy. Laryngoscope. 2001;111(4 Pt 1):681-7. PubMed PMID: 11359140.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Juvenile nasopharyngeal angiofibroma: management and therapy. AU - Scholtz,A W, AU - Appenroth,E, AU - Kammen-Jolly,K, AU - Scholtz,L U, AU - Thumfart,W F, PY - 2001/5/19/pubmed PY - 2001/6/23/medline PY - 2001/5/19/entrez SP - 681 EP - 7 JF - The Laryngoscope JO - Laryngoscope VL - 111 IS - 4 Pt 1 N2 - OBJECTIVE: To conduct a review of contemporary approaches on the diagnostic-preoperative, operative, and postoperative methods in the management of juvenile nasopharyngeal angiofibroma (JNA). STUDY DESIGN: Retrospective study of 14 cases of JNA resection at the Department of Otorhinolaryngology, University of Innsbruck (Innsbruck, Austria) between 1987 and 1998. METHODS: Data was obtained for each patient regarding age, presenting symptoms, duration of symptoms, biopsy findings, tumor location, administration of preoperative angiography and embolization, and surgical approach. The follow-up period ranged from 1 to 13 years. RESULTS: Based on the histological evaluation by the preoperative biopsy and the tumor location, several surgical approaches were applied. A transnasal endoscopic procedure was employed in seven cases. The preoperative embolization and the intranasal approach with the potassium titanyl phosphate laser minimized blood loss. The recurrence rate was at a low of 15%. CONCLUSION: The surgical approach should be determined by tumor location, tumor size, and effectiveness of tumor embolization. For patients with JNA with tumor extension involving the nasopharynx, the nasal cavity, the paranasal sinuses, and the pterygopalatine fossa, the transnasal endoscopic technique offers a minimally invasive resection of the entire tumor mass with minimal morphological disturbance. SN - 0023-852X UR - https://www.unboundmedicine.com/medline/citation/11359140/Juvenile_nasopharyngeal_angiofibroma:_management_and_therapy_ L2 - https://doi.org/10.1097/00005537-200104000-00022 DB - PRIME DP - Unbound Medicine ER -